FIELD: pharmaceutical chemistry. SUBSTANCE: agent contains sodium DNA salt and is characterized by molecular weight no higher than 500000 and hyperchromic effect with iron oxide at least 10%. Ratio of sodium DNA salt to iron oxide is equal to (145-1750):91-6). EFFECT: expanded antiviral spectrum and enabled treatment of disseminated sclerosis, HIV infection, and herpes. 6 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING IMMUNOTROPIC ANTIVARAL DRUG | 2000 |
|
RU2172632C1 |
| METHOD OF PRODUCING ANTIVIRAL DRUG | 2020 |
|
RU2739186C1 |
| DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
| METHOD FOR TREATMENT OF HEMOPOIESIS DISORDERS | 1993 |
|
RU2063228C1 |
| METHOD FOR PRODUCTION OF APYROGENIC IMMUNOMODULATING AGENT | 2006 |
|
RU2309759C1 |
| METHOD FOR PRODUCING IMMUNOTROPIC STERILE APYROGENIC TOLERANT PREPARATION BASED ON LOW-MOLECULAR NATIVE DEOXYRIBONUCLEIC ACID SODIUM SALT | 2003 |
|
RU2236853C1 |
| METHOD OF PREPARING SUBSTANCE SHOWING ANTIVIRAL ACTIVITY | 1993 |
|
RU2049479C1 |
| PROCESS OF PRODUCTION OF SODIUM DNA SALT FROM ANIMAL RAW MATERIAL AND BIOREACTOR FOR ITS REALIZATION | 1993 |
|
RU2005724C1 |
| ANTIVIRAL AGENT TO RNA- AND DNA-CONTAINING VIRUSES | 1996 |
|
RU2136286C1 |
| CREAM FOR FACE SKIN | 1992 |
|
RU2020923C1 |
